In part of the AML cases (1/19 in our CD34-positive AML population, AML-808), the CD34+CD38– compartment can not be segregated into HSC and LSC by expression of aberrant immunophenotypic markers or by scatter properties. This evidence concerns the gene CD38 and acute myeloid leukemia.